Johnson & Johnson logo

Johnson & Johnson (JNJ)

Market Closed
16 Oct, 08:00 PM
NYSE NYSE
$
255. 56
+2.28
+0.9002%
$
615.87B Market Cap
29.06 P/E Ratio
0.69% Div Yield
6.55M Volume
9.91 Eps
$ 253.28
Previous Close
Add Transaction
Day Range
254 257.55
Year Range
184.66 281.07
Want to track JNJ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
2 Bulletproof Dividend Stocks to Buy in May

2 Bulletproof Dividend Stocks to Buy in May

Dividend stock investing has long been a cornerstone for building wealth, offering investors a steady stream of passive income while providing a buffer against market volatility.

247wallst | 1 year ago
J&J-backed HistoSonics explores sale at $2.5 billion valuation, FT reports

J&J-backed HistoSonics explores sale at $2.5 billion valuation, FT reports

HistoSonics, a medical technology company backed by Johnson & Johnson , is exploring a potential sale after receiving multiple takeover approaches, the Financial Times reported on Friday, citing people familiar with the matter.

Reuters | 1 year ago
3 Industry Behemoths Are Rewarding Investors With Dividend Bumps

3 Industry Behemoths Are Rewarding Investors With Dividend Bumps

In a market where investors are increasingly seeking stability and reliable returns, several industry giants have stepped up with significant dividend increases. Johnson & Johnson NYSE: JNJ, Costco Wholesale NASDAQ: COST, and NASDAQ NASDAQ: NDAQ have each announced meaningful hikes to their quarterly payouts, reinforcing their commitment to shareholder value even amid broader market volatility.

Marketbeat | 1 year ago
3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S.

3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S.

Amid recession worries and tumbling markets; President Trump's tariffs are still helping the U.S. economy achieve key wins. Many huge corporations have announced plans to invest billions in U.S. manufacturing.

Marketbeat | 1 year ago
Dividend Kings Face-Off: Johnson & Johnson (JNJ) Vs. Procter & Gamble (PG)

Dividend Kings Face-Off: Johnson & Johnson (JNJ) Vs. Procter & Gamble (PG)

If you are someone who thinks investments should generate regular income, it is important to watch out for dividend stocks.

247wallst | 1 year ago
Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know

Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know

Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks | 1 year ago
Dividend Kings Down Today: Why Johnson & Johnson (JNJ), Coca-Cola (KO) and Procter & Gamble (PG) Are Sliding

Dividend Kings Down Today: Why Johnson & Johnson (JNJ), Coca-Cola (KO) and Procter & Gamble (PG) Are Sliding

Some analysts expect Procter & Gamble to cut its forecast thanks to uncertainty over spending with global trade tensions.

247wallst | 1 year ago
Why Johnson & Johnson (JNJ) is a Top Value Stock for the Long-Term

Why Johnson & Johnson (JNJ) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 1 year ago
2 Recession-Proof Stocks to Buy With a Better Credit Rating Than the U.S. Government

2 Recession-Proof Stocks to Buy With a Better Credit Rating Than the U.S. Government

In 2011, following the difficulty caused by the Great Recession, S&P Global Ratings (formerly Standard & Poor's) downgraded the long-term credit outlook of the United States from its highest designation of AAA to AA+, citing budgetary issues. Fitch once again downgraded U.S. credit in 2023 and Moody's recently suggested it's contemplating a similar move.

Fool | 1 year ago
Johnson & Johnson Pivots Its AI Strategy

Johnson & Johnson Pivots Its AI Strategy

The company is making a shift to focus on only the highest-value GenAI use cases and shut down pilots that were redundant or underdelivering.

Wsj | 1 year ago
Here's How You Should Play JNJ Stock After Q1 Earnings Beat

Here's How You Should Play JNJ Stock After Q1 Earnings Beat

Those who own JNJ stock may stay invested for some time to see how the company achieves growth in 2025 amid the various challenges.

Zacks | 1 year ago
The Relief Rally Is Over: 4 Incredible Dividend Monarchs Are Our Safest Ideas Now

The Relief Rally Is Over: 4 Incredible Dividend Monarchs Are Our Safest Ideas Now

While it was fun while it lasted, as we have discussed before, inevitably, after vicious sell-offs like the one we saw from the market peak in February, which pushed the S&P 500 and the Nasdaq quickly into a brief bear market 20% decline territory, there is the potential for stunning bear market rallies.

247wallst | 1 year ago
Loading...
Load More